Reuters logo
BRIEF-Staidson Beijing BioPharmaceuticals says shareholding structure change
November 7, 2017 / 5:58 AM / in 11 days

BRIEF-Staidson Beijing BioPharmaceuticals says shareholding structure change

Nov 7(Reuters) - Staidson Beijing BioPharmaceuticals Co Ltd

* Says co’s shareholders, Xiangtang Group and parties acting in concert cut stake in the co to 22.6 percent in total from 32.1 percent

Source text in Chinese: goo.gl/3Z3weG

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below